Chongqing Carelife Pharmaceutical Co., Ltd. FDA Record
Chongqing Carelife Pharmaceutical Co., Ltd. has 0 FDA recalls, 11 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Chongqing Carelife Pharmaceutical Co., Ltd., the most recent on Feb 14, 2017.
- Latest inspection
- Mar 28, 2025 · NAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 8, 2026 | File dated Nov 3, 2026 | Current |
| 510(k) clearances | 0 | Nov 8, 2026 | File dated Nov 2, 2026 | Current |
| Inspections | 11 | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 1 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 0 | 0 | 0 | 0 |
| 2024 | 1 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 1 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 2 | 1 | 1 | 0 | 0 |
Reviewing Chongqing Carelife Pharmaceutical Co., Ltd. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Chongqing Carelife Pharmaceutical Co., Ltd. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Chongqing Carelife Pharmaceutical Co., Ltd. FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Feb 14, 2017 · Record page |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Mar 28, 2025 | Chongqing, China | Drugs | No Action Indicated (NAI) | 3011903543 |
| Mar 22, 2024 | Chongqing, China | Veterinary | No Action Indicated (NAI) | 3005256542 |
| Jul 19, 2019 | Chongqing, China | Drugs | No Action Indicated (NAI) | 3011903543 |
| Nov 30, 2017 | Chongqing, China | Drugs | Official Action Indicated (OAI) | 3011903543 |
| Jul 26, 2017 | Chongqing, China | Veterinary | No Action Indicated (NAI) | 3005256542 |
| May 19, 2016 | Chongqing, China | Drugs | Official Action Indicated (OAI) | 3011903543 |
| Sep 25, 2015 | Chongqing, China | Drugs | No Action Indicated (NAI) | 3005256542 |
| Oct 31, 2013 | Chongqing, China | Drugs | No Action Indicated (NAI) | 3005256542 |
| Oct 18, 2013 | Chongqing, China | Drugs | Voluntary Action Indicated (VAI) | 3011903543 |
| Jul 7, 2011 | Chongqing, China | Veterinary | No Action Indicated (NAI) | 3005256542 |
| Jul 30, 2010 | Chongqing, China | Drugs | Voluntary Action Indicated (VAI) | 3011903543 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 1 compliance action under Chongqing Carelife Pharmaceutical Co., Ltd.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3011903543 | Chongqing, China | 6 | Mar 28, 2025 |
| FEI 3005256542 | Chongqing, China | 5 | Mar 22, 2024 |
Chongqing Carelife Pharmaceutical Co., Ltd. and the FDA: common questions
Has Chongqing Carelife Pharmaceutical Co., Ltd. received an FDA warning letter?
Yes. FDA has issued 1 warning letter to Chongqing Carelife Pharmaceutical Co., Ltd.. The most recent is dated Feb 14, 2017.
Has Chongqing Carelife Pharmaceutical Co., Ltd. received an FDA Form 483?
FDA has not published a Form 483 for "Chongqing Carelife Pharmaceutical Co., Ltd." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Chongqing Carelife Pharmaceutical Co., Ltd.?
The most recent FDA inspection on file ended Mar 28, 2025 at Chongqing, China and was classified NAI. FDA has 11 inspections of Chongqing Carelife Pharmaceutical Co., Ltd. on file, 2 of them classified OAI (official action indicated).
Need more than this page shows? Ask about Chongqing Carelife Pharmaceutical Co., Ltd. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.